GRCK Grey Cloak Tech Inc. Introduces ‘Clinical IMMUNE™’ to Combat Respiratory Symptoms https://finance.yahoo.com/news/grey-cloak-tech-inc-introduces-123000510.html?.tsrc=fin-srch
GRCK Grey Cloak Tech Inc. Launches Customer Relationship Management (CRM) Program to Increase Sales and Retention https://finance.yahoo.com/news/grey-cloak-tech-inc-launches-123000610.html
GRCK Grey Cloak Tech Inc. Files Application to Upgrade to OTCQB https://finance.yahoo.com/news/grey-cloak-tech-inc-files-123000227.html?.tsrc=fin-srch
GRCK Grey Cloak Tech Inc. Files Application to Upgrade to OTCQB https://finance.yahoo.com/news/grey-cloak-tech-inc-files-123000227.html?.tsrc=fin-srch
$GRCK Trickle Research has released an independent corporate analysis with target price of $0.17 https://finance.yahoo.com/news/grey-cloak-tech-inc-releases-123000885.html?.tsrc=fin-srch
GRCK Grey Cloak Tech Inc. Announces Strategic Equity Investment from the Medical Community https://finance.yahoo.com/news/grey-cloak-tech-inc-announces-133000059.html
GRCK Grey Cloak Tech Releases Study of Fuel4Thought Brain Booster https://finance.yahoo.com/news/grey-cloak-tech-releases-study-113000258.html?.tsrc=fin-srch
GRCK Grey Cloak Tech Inc. Subsidiary BergaMet NA™ Announces Sales Agreement with Major Key Account, Xymogen® https://finance.yahoo.com/news/grey-cloak-tech-inc-subsidiary-133000748.html?.tsrc=fin-srch
GRCK Grey Cloak Tech Completes Successful Pilot Study on its Fuel4Thought™ Migraine Formula with Positive Results https://finance.yahoo.com/news/grey-cloak-tech-completes-successful-131800296.html?.tsrc=fin-srch
GRCK Grey Cloak Tech Fuel4Thought™ Migraine Formula Results Published in World Journal of Advanced Research and Reviews https://finance.yahoo.com/news/grey...9.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr